Related Experiment Video
Updated: Mar 12, 2026
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Loss-of-function screens of druggable targetome against cancer stem-like cells
Mee Song1, Hani Lee2, Myung-Hee Nam3
1Center for Advanced Bioinformatics and Systems Medicine, Sookmyung Women's University, Seoul, Korea.
Abstract:
Cancer stem-like cells (CSLCs) contribute to the initiation and recurrence of tumors and to their resistance to conventional therapies. In this study, small interfering RNA (siRNA)-based screening of ∼4800 druggable genes in 3-dimensional CSLC cultures in comparison to 2-dimensional bulk cultures of U87 glioma cells revealed 3 groups of genes essential for the following: survival of the CSLC population only, bulk-cultured population only, or both populations. While diverse biologic processes were associated with siRNAs reducing the bulk-cultured population, CSLC-eliminating siRNAs were enriched in a few functional categories, such as lipid metabolism, protein metabolism, and gene expression. Interestingly, siRNAs that selectively reduced CSLC only were found to target genes for cholesterol and unsaturated fatty acid synthesis. The lipidomic profile of CSLCs revealed increased levels of monounsaturated lipids. Pharmacologic blockage of these target pathways reduced CSLCs, and this effect was eliminated by addition of downstream metabolite products. The present CSLC-sensitive target categories provide a useful resource that can be exploited for the selective elimination of CSLCs.-Song, M., Lee, H., Nam, M.-H., Jeong, E., Kim, S., Hong, Y., Kim, N., Yim, H. Y., Yoo, Y.-J., Kim, J. S., Kim, J.-S., Cho, Y.-Y., Mills, G. B., Kim, W.-Y., Yoon, S. Loss-of-function screens of druggable targetome against cancer stem-like cells.
Insights
Targeting lipid metabolism pathways, such as cholesterol and unsaturated fatty acid synthesis, can selectively eliminate cancer stem-like cells (CSLCs). This approach offers a new strategy for overcoming tumor recurrence and therapy resistance.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer stem-like cells (CSLCs) drive tumor initiation, recurrence, and therapeutic resistance.
- Identifying specific vulnerabilities of CSLCs is crucial for developing effective cancer treatments.
Purpose of the Study:
- To identify druggable genes essential for CSLC survival using a large-scale RNA interference screen.
- To discover novel therapeutic targets for the selective elimination of CSLCs.
Main Methods:
- Conducted a small interfering RNA (siRNA)-based screen of approximately 4800 druggable genes in 3D CSLC cultures versus 2D bulk U87 glioma cultures.
- Analyzed gene functions associated with CSLC-specific survival and identified enriched pathways.
- Performed lipidomic profiling of CSLCs and validated therapeutic targets using pharmacologic inhibition.
Main Results:
- Identified three distinct gene groups essential for CSLC survival, bulk cell survival, or both.
- CSLC-selective siRNAs were enriched in lipid metabolism, protein metabolism, and gene expression categories.
- Targeting cholesterol and unsaturated fatty acid synthesis pathways selectively reduced CSLCs, with effects reversed by metabolite addition.
Conclusions:
- Lipid metabolism pathways, particularly cholesterol and unsaturated fatty acid synthesis, represent key vulnerabilities of CSLCs.
- Pharmacologic targeting of these pathways offers a promising strategy for selective CSLC elimination.
- The identified CSLC-sensitive targets provide a valuable resource for developing novel anti-cancer therapies.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...